Eagle Bay Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Eagle Bay Advisors's LLY Position: Q3 2026 in Review
Eagle Bay Advisors reduced its Eli Lilly (LLY) stake by 0.99% in Q3 2026, selling an estimated $8.26K and leaving 699 shares worth $809K. The position accounts for 0.59% of the portfolio, ranked #38.
Eagle Bay Advisors first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. The position peaked at $847K in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Eagle Bay Advisors held 699 shares of Eli Lilly worth $809K as of Q3 2026.
- Eagle Bay Advisors sold 7 Eli Lilly shares in Q3 2026, an estimated $8.26K.
- Eli Lilly made up 0.59% of Eagle Bay Advisors's portfolio in Q3 2026, its #38 holding.
- Eagle Bay Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- Eagle Bay Advisors's Eli Lilly position peaked at $847K in Q2 2026.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Eagle Bay Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.